Key result
IV diazepam linked to lower LVEDP and aortic pressure regardless of CAD status.
Why the study?
The systemic and coronary hemodynamic effects of diazepam in patients with normal and diseased coronary arteries were not well characterized.
Does intravenous diazepam affect systemic and coronary hemodynamics in patients undergoing coronary angiography?
Observational (n=20)
Does intravenous diazepam affect systemic and coronary hemodynamics in patients undergoing coronary angiography?
Answers are grounded in this paper and cite their sources.
Intravenous diazepam provides a nitroglycerin-like reduction in preload and afterload, decreasing myocardial oxygen demand during coronary angiography.
In 12 patients with significant coronary artery disease (group I) and in eight patients with normal coronary arteries (group II), 5 to 8.5 mg of diazepam was given intravenously before coronary angiography. Adequate sedation was obtained in 17 patients. Hypoventilation occurred in all patients but was without clinical correlate. Coronary and cardiovascular effects were assessed before as well as 10 and 20 min after diazepam. Heart rate was unchanged and aortic pressure (AP) decreased significantly ( P < 0.01) in most patients. Cardiac index decreased only in patients of group II ( P < 0.01). Of particular interest was a constant fall in left ventricular end-diastolic pressure (LVEDP) in both groups, ( P < 0.01) and ( P < 0.05) at 10 and 20 min respectively in group I and ( P < 0.01) at 10 and 20 min in group II. Tension-time index and myocardial oxygen consumption (MVO 2 ) were also significantly decreased ( P < 0.05) after diazepam in both groups. Since neither coronary blood flow nor coronary vascular resistance were modified by diazepam, the fall in LVEDP could be due to a decrease in AP (afterload) and/or in venous return (preload). The combination of these effects could reduce intra-cavitary volume, myocardial wall tension and left ventricular MVO 2 . Our data therefore suggest that, in addition to its central sedative effects, diazepam also has a nitroglycerin-like action on the coronary and systemic circulation.
No takes yet. Share an insight, caveat, or question.
Côté et al. (1974) conducted an observational in Coronary artery disease or normal coronary arteries (n=20). Diazepam vs. Baseline was evaluated on Left ventricular end-diastolic pressure (LVEDP) (p=<0.01). Intravenous diazepam decreased left ventricular end-diastolic pressure and aortic pressure in patients with and without coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: